NCT02429258

Effect of Dapagliflozin on 24-hour Blood Glucose in T2DM Patients Inadequately Controlled With Either Metformin Or Insulin

• Status: Completed
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 226 (actual)
• Sponsor: AstraZeneca · Industry
• Sex: All
• Age: 18 Years – 75 Years
• Healthy volunteers: Not accepted

Summary

Effect of Dapagliflozin on 24-hour Blood Glucose in Type 2 Diabetes Patients Inadequately Controlled With Either Metformin Or Insulin

Detailed description

Effect of Dapagliflozin on 24-hour Blood Glucose in 92 Type 2 Diabetes Patients Inadequately Controlled With Either Metformin Or Insulin

Conditions

• Type II Diabetes

Interventions

Type	Name	Description
DRUG	Farxiga	Farxiga 10mg/day
DRUG	Placebo	Placebo
DRUG	Metformin	Metformin background therapy \>/= 1500mg/day
DRUG	Insulin	Insulin \>/= 30 units

Timeline

• Start date: 2015-05-01
• Primary completion: 2015-10-01
• Completion: 2015-10-01
• First posted: 2015-04-29
• Last updated: 2017-06-14
• Results posted: 2017-04-11

Locations

26 sites across 1 country: United States